Although many anecdotal reports indicate that marijuana and its active constituent, delta-9-tetrahydrocannabinol (delta-9-THC), may reduce pain sensation1,2, studies of humans have produced inconsistent results3,4,5,6. In animal studies, the apparent pain-suppressing effects of delta-9-THC and other cannabinoid drugs7,8,9,10,11,12 are confounded by motor deficits13,14. Here we show that a brainstem circuit that contributes to the pain-suppressing effects of morphine15 is also required for the analgesic effects of cannabinoids. Inactivation of the rostral ventromedial medulla (RVM) prevents the analgesia but not the motor deficits produced by systemically administered cannabinoids. Furthermore, cannabinoids produce analgesia by modulating RVM neuronal activity in a manner similar to, but pharmacologically dissociable from, that of morphine. We also show that endogenous cannabinoids tonically regulate pain thresholds in part through the modulation of RVM neuronal activity. These results show that analgesia produced by cannabinoids and opioids involves similar brainstem circuitry and that cannabinoids are indeed centrally acting analgesics with a new mechanism of action.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Mikuriya, T. H. Marijuana: Medical Papers 1839–1972. (Medi-Comp Press, Oakland, California, (1973)).
Dunn, M. & Davis, R. The perceived effects of marijuana on spinal cord injured males. Paraplegia 12, 175 (1974).
Noyes, R., Brunk, S. F., Avery, D. H. & Canter, A. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin. Pharmacol. Ther. 18, 84–89 (1975).
Clark, W. C., Janal, M. N., Zeidenberg, P. & Nahas, G. G. Effects of moderate and high doses of marihuana on thermal pain: a sensory decision theory analysis. J. Clin. Pharmacol. 21 (Suppl.), 299–310 (1981).
Libman, E. & Stern, M. H. The effects of delta-9-THC on cutaneous sensitivity and its relation to personality. Person. Indiv. Diff. 6, 169–174 (1985).
Holdcroft, A. et al. Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia 52, 483–488 (1997).
Buxbaum, D., Sanders-Bush, E. & Efron, D. Analgesic activity of tetrahydrocannabinol (THC) in the rat and mouse. Fed. Proc. 28, 735 (1969).
Sofia, R. D., Nalepa, S. D., Harakel, J. J. & Vassar, H. B. Anti-edema and analgesic properties of delta-9-tetrahydrocannabinol (THC). J. Pharmacol. Exp. Ther. 186, 646–655 (1973).
Moss, D. E. & Johnson, R. L. Tonic analgesic effects of delta-9-tetrahydrocannabinol as measured with the formalin test. Eur. J. Pharmacol. 61, 313–315 (1980).
Lichtman, A. H. & Martin, B. R. Cannabinoid-induced antinociception is mediated by a spinal α-noradrenergic mechanism. Brain Res. 559, 309–314 (1991).
Martin, W. J., Hohmann, A. G. & Walker, J. M. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects. J. Neurosci. 16, 6601–6611 (1996).
Herzberg, U., Eliav, E., Bennett, G. J. & Kopin, I. J. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett. 221, 157–160 (1997).
Gough, A. L. & Olley, J. E. Delta-9-tetrahydrocannabinol and the extrapyramidal system. Psychopharmacol. 54, 87–99 (1977).
Ueki, S. Abnormal behavior induced by delta-9-tetrahydrocannabinol. Trends Pharmacol. Sci. 1, 126–129 (1980).
Mitchell, J. M., Lowe, D. & Fields, H. L. The contribution of the rostral ventromedial medulla to the antinoceceptive effects of systemic morphine in restrained and unrestrained rats. Neuroscience 87, 123–133 ((1998)).
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561–564 (1990).
Munro, S., Thomas, K. L. & Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61–65 (1993).
Devane, W. A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946–1949 (1992).
Stella, N., Schweitzer, P. & Piomelli, D. Asecond endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773–778 (1997).
Rinaldi-Carmona, M. et al. SR 14176A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240–244 (1994).
Tsou, K., Brown, S., Sanudo-Pena, M. C., Mackie, K. & Walker, J. M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83, 393–411 (1998).
Basbaum, A. I. & Fields, H. L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7, 309–338 (1984).
Martin, W. J., Tsou, K. & Walker, J. M. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci. Lett. 242, 33–36 (1998).
Fields, H. L., Vanegas, H., Hentall, I. D. & Zorman, G. Evidence that disinhibition of brain stem neurones contributes to morphine analgesia. Nature 306, 684–686 (1983).
Fields, H. L., Malick, A. & Burstein, R. Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. J. Neurophys. 74, 1742–1759 (1995).
Heinricher, M. M., Morgan, M. M. & Fields, H. L. Direct and indirect actions of morphine on medullary neurons that modulate nociception. Neuroscience 48, 533–543 (1992).
Pan, Z. Z. & Fields, H. L. Endogenous opioid-mediated inhibition of putative pain-modulating neurons in rat rostral ventromedial medulla. Neuroscience 74, 855–862 (1996).
Roychowdhury, S. M. & Fields, H. L. Endogenous opioids acting at a medullary µ-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray. Neuroscience 74, 863–872 (1996).
Richardson, J. D., Aanonsen, L. & Hargreaves, K. M. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J. Neurosci. 18 ((1998)).
Cadas, H., di Tomaso, E. & Piomelli, D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17, 1226–1242 (1997).
Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates (Academic Press, New York, (1986)).
This work was supported by the National Institute of Drug Abuse, the UCSF Center for the Neurobiology of Addiction and the Canadian MRC.
About this article
Cite this article
Meng, I., Manning, B., Martin, W. et al. An analgesia circuit activated by cannabinoids. Nature 395, 381–383 (1998). https://doi.org/10.1038/26481
The effect of cannabidiol on sevoflurane minimum alveolar concentration reduction produced by morphine in rats
Veterinary Anaesthesia and Analgesia (2021)
SGIP1 is involved in regulation of emotionality, mood, and nociception and modulates in vivo signalling of cannabinoid CB 1 receptors
British Journal of Pharmacology (2021)
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
Pharmacological Research (2021)
The Clinical Journal of Pain (2020)